+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Aspergillosis Treatment - Global Strategic Business Report - Product Thumbnail Image

Aspergillosis Treatment - Global Strategic Business Report

  • Report
  • January 2026
  • 374 Pages
  • Global
From
Duodenal Ulcer Treatment - Global Strategic Business Report - Product Thumbnail Image

Duodenal Ulcer Treatment - Global Strategic Business Report

  • Report
  • January 2026
  • 380 Pages
  • Global
From
Ankylosing Spondylitis - Global Strategic Business Report - Product Thumbnail Image

Ankylosing Spondylitis - Global Strategic Business Report

  • Report
  • January 2026
  • 271 Pages
  • Global
From
Neurology Clinical Trials - Global Strategic Business Report - Product Thumbnail Image

Neurology Clinical Trials - Global Strategic Business Report

  • Report
  • January 2026
  • 385 Pages
  • Global
From
Dermatology Drugs - Global Strategic Business Report - Product Thumbnail Image

Dermatology Drugs - Global Strategic Business Report

  • Report
  • January 2026
  • 372 Pages
  • Global
From
From
Naltrexone and Buprenorphine - Global Strategic Business Report - Product Thumbnail Image

Naltrexone and Buprenorphine - Global Strategic Business Report

  • Report
  • January 2026
  • 364 Pages
  • Global
From
Opioid Use Disorder - Global Strategic Business Report - Product Thumbnail Image

Opioid Use Disorder - Global Strategic Business Report

  • Report
  • January 2026
  • 177 Pages
  • Global
From
Loratadine Market - Global Strategic Business Report - Product Thumbnail Image

Loratadine Market - Global Strategic Business Report

  • Report
  • January 2026
  • 373 Pages
  • Global
From
Anti-Retroviral Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Retroviral Drugs - Global Strategic Business Report

  • Report
  • January 2026
  • 280 Pages
  • Global
From
Alexipharmic Drugs - Global Strategic Business Report - Product Thumbnail Image

Alexipharmic Drugs - Global Strategic Business Report

  • Report
  • January 2026
  • 290 Pages
  • Global
From
From
Erdosteine - Global Strategic Business Report - Product Thumbnail Image

Erdosteine - Global Strategic Business Report

  • Report
  • January 2026
  • 274 Pages
  • Global
From
Male Urinary Incontinence - Global Strategic Business Report - Product Thumbnail Image

Male Urinary Incontinence - Global Strategic Business Report

  • Report
  • January 2026
  • 563 Pages
  • Global
From
Cannabidiol (CBD) Pet - Global Strategic Business Report - Product Thumbnail Image

Cannabidiol (CBD) Pet - Global Strategic Business Report

  • Report
  • January 2026
  • 383 Pages
  • Global
From
Aniridia Treatment - Global Strategic Business Report - Product Thumbnail Image

Aniridia Treatment - Global Strategic Business Report

  • Report
  • January 2026
  • 368 Pages
  • Global
From
Facial Palsy - Global Strategic Business Report - Product Thumbnail Image

Facial Palsy - Global Strategic Business Report

  • Report
  • January 2026
  • 367 Pages
  • Global
From
Connective Tissue Diseases - Global Strategic Business Report - Product Thumbnail Image

Connective Tissue Diseases - Global Strategic Business Report

  • Report
  • January 2026
  • 385 Pages
  • Global
From
Capsaicin - Global Strategic Business Report - Product Thumbnail Image

Capsaicin - Global Strategic Business Report

  • Report
  • January 2026
  • 384 Pages
  • Global
From
Melatonin Supplements - Global Strategic Business Report - Product Thumbnail Image

Melatonin Supplements - Global Strategic Business Report

  • Report
  • January 2026
  • 376 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more